Works matching Myelosuppression

Results: 3357

Prospective Observational Study on the Risk Factors of Chemotherapy-Induced Myelosuppression and Its Management in a Tertiary Care Hospital.

Published in:

Indian Journal of Medical & Paediatric Oncology, 2024, v. 45, n. 5, p. 416, doi. 10.1055/s-0043-1770905

By:

Keziah, D.;
Bindhiya, M.;
Jayaprakash, M.;
Prudence, Rodrigues A.

Publication type:

Article

Asperuloside alleviates cyclophosphamide‐induced myelosuppression by promoting AMPK/mTOR pathway‐mediated autophagy.

Published in:

Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 2, p. 1, doi. 10.1002/jbt.23641

By:

Che, Hong;
Li, Linlin;
Zhao, Bingjie;
Hu, Lian;
Xiao, Li;
Liu, Peijia;
Liu, Songshan;
Hou, Zhufa

Publication type:

Article

High-altitude hypoxia exacerbates chemotherapy-induced myelosuppression by lowering serum G-CSF/GM-CSF and regulating apoptosis and proliferation.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02611-2

By:

Shi, Jing;
Zhao, Fuxing;
Qiu, Tianlei;
Ren, Dengfeng;
Li, Zitao;
Ma, Junli;
Zhao, Jiuda

Publication type:

Article

Transcriptome Profiling Analysis Reveals the Potential Mechanisms of Three Bioactive Ingredients of Fufang E'jiao Jiang During Chemotherapy-Induced Myelosuppression in Mice.

Published in:

Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00616

By:

Xue Li;
Yan Zhang;
Zhuping Hong;
Shuqing Gong;
Wei Liu;
Xiangshan Zhou;
Yangen Sun;
Jing Qian;
Haibin Qu

Publication type:

Article

A herbal formula, SYKT, reverses doxorubicin-induced myelosuppression and cardiotoxicity by inhibiting ROS-mediated apoptosis.

Published in:

Molecular Medicine Reports, 2017, v. 15, n. 4, p. 2057, doi. 10.3892/mmr.2017.6272

By:

TING CHEN;
HONG-MEI SHEN;
ZHI-YONG DENG;
ZUO-ZHANG YANG;
RUI-LIAN ZHAO;
LI WANG;
ZHI-PING FENG;
CHAO LIU;
WEN-HUI LI;
ZHI-JIE LIU

Publication type:

Article

HER2 exon 20 insertion mutations and myelosuppression in lung adenocarcinoma patient: a case report and response to trastuzumab deruxtecan.

Published in:

Journal of Cardiothoracic Surgery, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13019-023-02181-w

By:

Wang, Bin;
Song, Yang;
Yang, Xin;
Chen, Chuan

Publication type:

Article

Association between chemotherapy-induced myelosuppression and curative efficacy of 2-cycle chemotherapy in small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 2, p. 151, doi. 10.1007/s00280-023-04608-6

By:

Wang, Xinyu;
Gu, Shujun;
Wen, Jingli;
Zhang, Lixi;
Qi, Xu

Publication type:

Article

Astragaloside IV and Saponins of Rhizoma Polygonati Cure Cyclophosphamide-Induced Myelosuppression in Lung Adenocarcinoma via Down-Regulating miR-142-3p.

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.630921

By:

Gu, Xian;
Zhu, Ling-yu;
Xu, Zhen-ye;
Shen, Ke-ping

Publication type:

Article

Relation of age with myelosuppression induced by the CHOP regimen in patients with Non-Hodgkin’s Lymphoma.

Published in:

Cancer Therapy, 2009, v. 7, p. 133

By:

Fumiaki Kitazawa;
Toshio Abe;
Kumi Ueda;
Satoshi Murakami;
Kohshi Nishiguchi;
Kohji Takara;
Teruyoshi Yokoyama;
Hikofumi Sugii

Publication type:

Article

Real-World Clinical Outcomes of Trilaciclib for the Prevention of Myelosuppression in Patients with Esophageal Cancer Undergoing Chemotherapy.

Published in:

Current Oncology, 2025, v. 32, n. 4, p. 189, doi. 10.3390/curroncol32040189

By:

Chen, Hui;
Yan, Jingze;
Liu, Zeyuan;
Ge, Xiaolin;
Sun, Xinchen;
Xia, Xiaojie

Publication type:

Article

Nucleosides and amino acids, isolated from Cordyceps sinensis, protected against cyclophosphamide-induced myelosuppression in mice.

Published in:

Natural Product Research, 2022, v. 36, n. 23, p. 6056, doi. 10.1080/14786419.2022.2043307

By:

Zhang, Yu;
Liu, Jie;
Wang, Yan;
Sun, Chengpeng;
Li, Wenjia;
Qiu, Jianjian;
Qiao, Yanling;
Wu, Fan;
Huo, Xiaokui;
An, Yue;
Zhang, Baojing;
Ma, Shuangcheng;
Zheng, Jian;
Ma, Xiaochi

Publication type:

Article

Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring.

Published in:

2017

By:

Netterberg, Ida;
Nielsen, Elisabet;
Friberg, Lena;
Karlsson, Mats;
Nielsen, Elisabet I;
Friberg, Lena E;
Karlsson, Mats O

Publication type:

journal article

Improvement of icaritin on hematopoietic function in cyclophosphamide-induced myelosuppression mice.

Published in:

Immunopharmacology & Immunotoxicology, 2018, v. 40, n. 1, p. 25, doi. 10.1080/08923973.2017.1392564

By:

Sun, Chenghong;
Yang, Jian;
Pan, Lihong;
Guo, Na;
Li, Bingbing;
Yao, Jingchun;
Wang, Mingzhi;
Qi, Changpeng;
Zhang, Guimin;
Liu, Zhong

Publication type:

Article

Jian-Pi-Bu-Xue-Formula Alleviates Cyclophosphamide-Induced Myelosuppression via Up-Regulating NRF2/HO1/NQO1 Signaling.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.01302

By:

Huang, Qiuju;
Feng, Lizhi;
Li, Hang;
Zheng, Liang;
Qi, Xiaoxiao;
Wang, Ying;
Feng, Qian;
Liu, Zhongqiu;
Liu, Xiaohong;
Lu, Linlin

Publication type:

Article

Ginsenoside Rg3 for Chemotherapy-Induced Myelosuppression: A Meta-Analysis and Systematic Review.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00649

By:

Pan, Linlin;
Zhang, Tingting;
Cao, Hongfu;
Sun, Haiyang;
Liu, Guirong

Publication type:

Article

Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.845034

By:

Zhang, He;
Zhang, Lancao;
Yang, Chunhui;
Zhang, Yuyao;
Li, Jing;
Zhang, Xu;
Chen, Jinjin;
Huang, Baotai;
Zhao, Daqing;
Li, Xiangyan;
Zhang, Wei;
Qi, Bin

Publication type:

Article

Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.835616

By:

Saggam, Akash;
Kale, Prathamesh;
Shengule, Sushant;
Patil, Dada;
Gautam, Manish;
Tillu, Girish;
Joshi, Kalpana;
Gairola, Sunil;
Patwardhan, Bhushan

Publication type:

Article

Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.672769

By:

Chen, Zhao-Yang;
Zhu, Yang-Hui;
Zhou, Ling-Yan;
Shi, Wei-Qiao;
Qin, Zhou;
Wu, Bin;
Yan, Yu;
Pei, Yu-Wen;
Chao, Ning-Ning;
Zhang, Rui;
Wang, Mi-Ye;
Su, Ze-Hao;
Lu, Xiao-Jun;
He, Zhi-Yao;
Xu, Ting

Publication type:

Article

Transient chemotherapy‐induced alopecia after successful reversal of 5‐fluorouracil myelosuppression and neurotoxicosis in a 9‐month‐old dog.

Published in:

Australian Veterinary Journal, 2022, v. 100, n. 6, p. 236, doi. 10.1111/avj.13154

By:

Immelman, LM;
Goodman, IH;
Keller, N

Publication type:

Article

Effects of Yifukang Oral Liquid on Chemotherapy- and Radiotherapy-Induced Toxic and Side Effects of Myelosuppression, Leucopenia and Gastrointestinal Tract Disturbances.

Published in:

Tropical Journal of Pharmaceutical Research, 2015, v. 14, n. 11, p. 2023, doi. 10.4314/tjpr.v14i11.11

By:

Xi-Kui Tian;
Hong-Di Lv;
Qing-Hua Zhao;
Shao-Jun Hao;
Xiu-Li Geng;
Xi-Dong Wang;
Zheng-Chen Zhang;
Jian-Chang Zhao

Publication type:

Article

Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening Myelosuppression.

Published in:

Medicina (1010660X), 2024, v. 60, n. 8, p. 1270, doi. 10.3390/medicina60081270

By:

Shalata, Walid;
Abu Jama, Ashraf;
Dudnik, Yulia;
Abu Saleh, Omar;
Shalata, Sondos;
Tourkey, Lena;
Sheva, Kim;
Meirovitz, Amichay;
Yakobson, Alexander

Publication type:

Article

Hematopoietic Effects of Angelica gigas Nakai Extract on Cyclophosphamide-Induced Myelosuppression.

Published in:

Plants (2223-7747), 2022, v. 11, n. 24, p. 3476, doi. 10.3390/plants11243476

By:

Kang, Mincheol;
Park, Seojin;
Chung, Yuseong;
Lim, Je-Oh;
Kang, Jae Seon;
Park, Jun Hong

Publication type:

Article

Quantitative evaluation of myelosuppression after chemotherapy for patients with ovarian cancer using material decomposition in dual-energy computed tomography.

Published in:

European Journal of Gynaecological Oncology, 2023, v. 44, n. 1, p. 79, doi. 10.22514/ejgo.2023.009

By:

Wanjing Bai;
Lin Li;
Gang Ning;
Xuesheng Li;
Xijian Chen;
Lingjun Jiang;
Xueru Yang;
Hanhong Zhou

Publication type:

Article

Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices.

Published in:

Cancer Medicine, 2023, v. 12, n. 8, p. 10020, doi. 10.1002/cam4.5738

By:

Hart, Lowell;
Ogbonnaya, Augustina;
Boykin, Kristen;
Deyoung, Kathryn;
Bailey, Ray;
Heritage, Trevor;
Lopez‐Gonzalez, Lorena;
Huang, Huan;
Gordan, Lucio

Publication type:

Article

Exosomal miR-122-5p is Related to the Degree of Myelosuppression Caused by Chemotherapy in Patients with Colorectal Cancer.

Published in:

Cancer Management & Research, 2021, v. 13, p. 8329, doi. 10.2147/CMAR.S332384

By:

Chen, Jinbao;
Wu, Wentao;
He, Xue;
Jia, Linlin;
Yang, Jiahua;
Si, Xianke;
Yu, Kun;
Li, Sen;
Qiu, Yanyan;
Xu, Ke;
Yin, Peihao;
Cao, Yijun;
Li, Qiong;
Li, Wei

Publication type:

Article

Factors Predicting Severe Myelosuppression and Its Influence on Fertility in Patients with Low-Risk Gestational Trophoblastic Neoplasia Receiving Single-Agent Methotrexate Chemotherapy.

Published in:

Cancer Management & Research, 2020, v. 12, p. 4107, doi. 10.2147/CMAR.S252664

By:

Tu, Xiaoyu;
Chen, Ruizhe;
Huang, Genping;
Lu, Nanjia;
Chen, Qin;
Bai, Xiaoxia;
Li, Baohua

Publication type:

Article

The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1157251

By:

Jingyue Qiu;
Dandan Sheng;
Fei Lin;
Peng Jiang;
Ning Shi

Publication type:

Article

Case report: NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a young Chinese female with systematic lupus erythematosus: a case analysis and literature review.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1001559

By:

Juan Gu;
Yupei Lin;
Yuhe Wang

Publication type:

Article

Cancer Patients' Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life.

Published in:

Patient Preference & Adherence, 2021, v. 15, p. 453, doi. 10.2147/PPA.S292462

By:

Epstein, Robert S;
Roy, Upal K Basu;
Aapro, Matti;
Salimi, Tehseen;
Moran, Donald;
Krenitsky, JoAnn;
Leone-Perkins, Megan L;
Girman, Cynthia;
Schlusser, Courtney;
Crawford, Jeffrey

Publication type:

Article

Low‐Intensity Pulsed Ultrasound Relieves Mild and Severe Myelosuppression Induced by Cyclophosphamide in Rabbits.

Published in:

Journal of Ultrasound in Medicine, 2019, v. 38, n. 10, p. 2721, doi. 10.1002/jum.14979

By:

Liu, Baoru;
Zhou, Weichen;
Wu, Junru;
Chen, Wenzhi;
Chen, Jinyun;
Wang, Yan

Publication type:

Article

A randomized trial of Bacteroides fragilis 839 on preventing chemotherapy-induced myelosuppression and gastrointestinal adverse effects in breast cancer patients.

Published in:

Asia Pacific Journal of Clinical Nutrition, 2024, v. 33, n. 1, p. 23, doi. 10.6133/apjcn.202403_33(1).0003

By:

Ting Zeng;
Yu-hong Deng;
Chu-hui Lin;
Xin-xin Chen;
Hai-xia Jia;
Xiao-wu Hu;
Ting Xia;
Yun Ling;
Le-hong Zhang;
Tengfei Cao

Publication type:

Article

Myeloprotective potential of Malus domestica (Apple) in Carboplatin induced myelosuppression in Swiss albino rats-A way to prevent Dengue and similar viral diseases.

Published in:

Annals of King Edward Medical University, 2018, v. 24, n. 4, p. 1

By:

Ahmad, Maaz;
Ahmad, Mussab;
Munir, Tehreem

Publication type:

Article

Imatinib-induced severe hematological toxicity: Prolonged myelosuppression resulting from extraordinary sensitivity in an old age.

Published in:

European Journal of Inflammation, 2023, p. 1, doi. 10.1177/1721727X231158468

By:

Xu, Jia;
Ju, Bo;
Yang, Xiao-Dong;
Xiu, Nuan-Nuan;
Zhao, Xi-Chen

Publication type:

Article

Imatinib-induced severe hematological toxicity: Prolonged myelosuppression resulting from extraordinary sensitivity in an old age.

Published in:

European Journal of Inflammation, 2023, v. 21, p. 1, doi. 10.1177/1721727X231158468

By:

Jia Xu;
Bo Ju;
Xiao-Dong Yang;
Nuan-Nuan Xiu;
Xi-Chen Zhao

Publication type:

Article

Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery.

Published in:

Drug Delivery, 2022, v. 29, n. 1, p. 728, doi. 10.1080/10717544.2022.2046892

By:

Yuxin Chen;
Lulu Han;
Xiaoyan Qiu;
Meng Wang;
Zheng Chen;
Ying Cai;
Yong Xin;
Yanfang Lv;
Ankang Hu;
Dafei Chai;
Liantao Li;
Huizhong Li;
Junnian Zheng;
Gang Wang

Publication type:

Article

Protective effect of 20(R)-ginsenoside Rg3 on chemotherapy-induced myelosuppression in mice.

Published in:

Pharmacognosy Magazine, 2022, v. 18, n. 79, p. 685, doi. 10.4103/pm.pm_451_21

By:

Fu, Zhengfeng;
Sun, Nian;
Li, Shuqi;
Han, Jiahong;
Lang, Shiyue;
Yue, Xiuyong;
Cai, Enbo

Publication type:

Article

H<sub>2</sub>S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets.

Published in:

Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0244-7

By:

Huan-Di Liu;
Ai-Jie Zhang;
Jing-Jing Xu;
Ying Chen;
Yi-Chun Zhu

Publication type:

Article

Nitrogen mustard hydrochloride-induced acute respiratory failure and myelosuppression: A case report.

Published in:

2015

By:

XIAOJUAN ZHANG;
ZHIDAN ZHANG;
SONG CHEN;
DONGMEI ZHAO;
FANGXIAO ZHANG;
ZIWEI HU;
FENG XIAO;
XIAOCHUN MA

Publication type:

Case Study

Myelosuppression by chemotherapy in obese patients with gynecological cancers.

Published in:

2016

By:

Kamimura, Kensuke;
Matsumoto, Yoshifumi;
Zhou, Qiliang;
Moriyama, Masato;
Saijo, Yasuo

Publication type:

journal article

STS1 and STS2 Phosphatase Inhibitor Baicalein Enhances the Expansion of Hematopoietic and Progenitor Stem Cells and Alleviates 5-Fluorouracil-Induced Myelosuppression.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2987, doi. 10.3390/ijms24032987

By:

Li, Na;
Wang, Yanhong;
Wang, Anqing;
Zhang, Jing;
Jia, Chaoran;
Yu, Chunlei;
Song, Zhenbo;
Wang, Shuyue;
Liu, Lei;
Yi, Jingwen;
Bao, Yongli;
Huang, Yanxin;
Sun, Luguo

Publication type:

Article

Structural identifiability for mathematical pharmacology: models of myelosuppression.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2018, v. 45, n. 1, p. 79, doi. 10.1007/s10928-018-9569-x

By:

Evans, Neil D.;
Cheung, S. Y. Amy;
Yates, James W. T.

Publication type:

Article

A Case Report Of Linezolid (Lzd) Induced Complete Myelosuppression.

Published in:

2017

By:

Trivedi, Vedang;
Rana, Devang;
Gupta, Sapna;
Malhotra, Supriya

Publication type:

Case Study

The association of four genetic variants with myelosuppression in gemcitabine‐treated Japanese is not evident in gemcitabine/carboplatin‐treated Swedes.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 513, doi. 10.1111/bcpt.13712

By:

Björn, Niclas;
Jakobsen, Ingrid;
Udagawa, Chihiro;
Brandén, Eva;
Koyi, Hirsh;
Lewensohn, Rolf;
De Petris, Luigi;
Zembutsu, Hitoshi;
Gréen, Henrik

Publication type:

Article

Hemostimulating Effects of c-Jun N-Terminal Kinase (JNK) Inhibitor during Cytostatic Myelosuppression and Mechanisms of Their Development.

Published in:

Bulletin of Experimental Biology & Medicine, 2020, v. 169, n. 3, p. 332, doi. 10.1007/s10517-020-04880-z

By:

Zyuz'kov, G. N.;
Zhdanov, V. V.;
Miroshnichenko, L. A.;
Simanina, E. V.;
Polyakova, T. Yu.;
Stavrova, L. A.;
Agafonov, V. I.;
Minakova, M. Yu.;
Danilets, M. G.;
Ligacheva, A. A.

Publication type:

Article

Splenunculus mimicking splenomegaly in a patient with synchronous herpes simplex 1 viremia and myelosuppression.

Published in:

2022

By:

Paul, Dion A.;
La, Paul Bao Duy;
Abasszade, Joshua Haron

Publication type:

Case Study

Trilaciclib: A Novel Approach to Mitigate Chemotherapy-Induced Myelosuppression in Cancer Treatment.

Published in:

Indian Journal of Medical & Paediatric Oncology, 2024, v. 45, n. 4, p. 320, doi. 10.1055/s-0044-1786017

By:

Kapoor, Mayank;
Sehrawat, Amit;
Sundriyal, Deepak

Publication type:

Article

Lurasidone Induced Thrombocytopenia: Is it a Signal of Drug Induced Myelosuppression?

Published in:

Indian Journal of Psychological Medicine, 2018, v. 40, n. 2, p. 191, doi. 10.4103/IJPSYM.IJPSYM_374_17

By:

Rafi, Mohammad;
Goyal, Chhaya;
Reddy, Pooja;
Reddy, Shrikanth

Publication type:

Article

Prevalence of hepatotoxicity and myelosuppression with alternate day use of azathioprine and glucocorticoids for treatment of dermatological conditions in dogs.

Published in:

Veterinary Dermatology, 2022, v. 33, n. 6, p. 503, doi. 10.1111/vde.13115

By:

Eberhardy, Aurrielle C.;
Heinrich, Nicole A.;
McFadden, Rendina A.;
Reiter, Lisa V.

Publication type:

Article

A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer.

Published in:

Pharmaceutics, 2022, v. 14, n. 5, p. 914, doi. 10.3390/pharmaceutics14050914

By:

Park, Kyemyung;
Kim, Yukyung;
Son, Mijeong;
Chae, Dongwoo;
Park, Kyungsoo

Publication type:

Article

2646. Incidence of Myelosuppression Related to Valganciclovir Prophylaxis in Solid-Organ Transplant Recipients at High Risk of CMV Disease.

Published in:

Open Forum Infectious Diseases, 2019, v. 6, p. S925, doi. 10.1093/ofid/ofz360.2324

By:

Belga, Sara;
Hernandez, Cristina;
Kabbani, Dima;
Cervera, Carlos

Publication type:

Article